logo
This Startup Says It Can Clean Your Blood of Microplastics

This Startup Says It Can Clean Your Blood of Microplastics

WIRED02-04-2025
Apr 2, 2025 7:00 AM The elective medical industry is cashing in on plastic pollution fears, but the evidence of harm from microplastics is still deeply uncertain. Photograph: Courtesy of Clarify Clinics
This is a non-exhaustative list of places microplastics have been found: Mount Everest, the Mariana Trench, Antarctic snow, clouds, plankton, turtles, whales, cattle, birds, tap water, beer, salt, human plancentas, semen, breast milk, feces, testicles, livers, brains, arteries, and blood.
My blood, specifically. In early March I milked a few drops out of my fingertips and sent the sample to be tested for microplastics. I was in the London office of Clarify Clinics—a firm that offers to cleanse your blood of microplastics, forever chemicals, and other toxins, in treatments that start at £9,750 ($12,636).
Each week around 10 to 15 people walk into the basement clinic just off Harley Street—a road famed for its private clinics and wealthy clientele. After a consultation, the patients settle down in an armchair for the treatment. Blood is drawn from a cannula into a machine that separates out the plasma from blood cells. That plasma is filtered through a column that is supposed to trap microplastics and other undesirable chemicals, before being mixed back with the blood cells and pumped back into the patient. All-in-all the process runs for up to two hours—enough time to process 50 to 80 percent of the blood plasma volume.
'Once it's running, you feel nothing. It's very comfortable,' says Yael Cohen, CEO of Clarify Clinic. 'Patients take calls, do Zooms, watch movies, sleep. The ones who sleep are my favorite.' They come for all kinds of reasons, Cohen says: Some are suffering with chronic fatigue, others with brain fog or long Covid. The clinic also runs treatments marketed toward people on Ozempic-style weight-loss drugs, looking to conceive, or ward off dementia.
What Clarify sells them is the hope of easing their symptoms by ridding their blood of microplastics, or other potential contaminants such as PFAS chemicals (per- and polyfluoroalkyl substances) and pesticides. But the science on how microplastics affect our health is still far from conclusive. A 2022 WHO report into microplastics concluded that there wasn't yet enough evidence to figure out whether they posed a risk to human health. We don't know microplastics are safe, the report concluded, but we also don't know the risks they might pose.
'The dose makes the poison,' says Frederic Béen, an environmental contaminants researcher at the Amsterdam Institute for Life and Environment. 'That's the reason why it is important to determine accurately how much microplastics or any other type of environmental contaminants humans are exposed to.'
There have been an onslaught of scientific papers that have tracked microplastics to every inch of the Earth's surface and deep within our bodies, but very few attempt to tease out the impact these have on our health. A 2022 review article found that microplastics were associated with harm to human cells, but didn't examine actual health outcomes in living humans. A study in 2024 found that people who had microplastics in the fatty plaque within their carotid arteries had a higher risk of heart attacks and strokes than people who didn't have microplastics in their arteries.
But the 2024 study didn't establish any causal link between microplastics and health. The study was only observational, so it couldn't prove that the presence of microplastics caused the higher risk of death for certain patients. There were also differences between the two groups studied—patients with microplastics in their arteries were more likely to be men, have cardiovascular disease, and smoke. It could be that these factors—or another unknown influence—were actually causing the difference in risk of death between the two groups.
The same uncertainties apply when it comes to measuring microplastics. I wasn't particularly scientific when I milked that blood from my fingertip. Plastic fibers from my clothing or packaging could easily have made their way into my sample, and the same is true when any sample is analyzed, whether it's from the environment or a human body. Béen and his colleagues go to extreme lengths to try to avoid contamination when they're analyzing blood samples for microplastics. All of the equipment they use to take samples is plastic-free, the air in their lab is filtered, and they only wear cotton when working with the samples. 'What we do is to make sure there is no plastic contamination, or to minimize it as much as possible given that microplastics are everywhere.'
We live in such a plastic-saturated world that it's difficult to measure microplastics accurately, let alone link them to health outcomes. But Cohen says that her patients report higher energy levels or better sleep after trying the treatment. Cohen tracks her sleep quality on an Oura ring and says that before the treatment a score of 70 would be good for her, but in the six weeks after she tried the treatment she hadn't dropped below 90—which, according to the Oura website, indicates 'optimal' sleep.
Most of the patients come to the clinic through word of mouth. 'People are posting it, they're talking about it,' Cohen says. Patients post their blood microplastic results online before and after the treatment. 'I think it's a badge of honor to be doing your future self a favor,' she says.
Blood microplastic cleansing is just the latest in a long line of treatments based on uncertain evidence targeting wealthy individuals worried about their health. In the Bahamas, people pay tens of thousands of dollars for stem cell injections of unproven benefit. Longevity influencer Bryan Johnson has touted the benefits of total plasma exchange—removing plasma from the blood and supplementing it with proteins and antibodies on a regular basis.
'He's a big platform, and he is spending a lot of time and energy finding the things that move the needle the most,' says Cohen.
In extreme cases of exposure to pollutants, some form of blood cleaning can be necessary. Earlier this year, residents of Jersey, an island in the English Channel, were recommended bloodletting after firefighting foams containing PFAS polluted drinking water supplies. High levels of PFAS exposure have been linked to some cancers and issues with brain development and thyroid function. Bloodletting would clean the blood over time by removing contaminated blood and allowing the body to replenish the blood naturally.
But for most people we simply don't know what their blood microplastics levels are, or whether they are anything to worry about. My fingerprick test found around 190 microplastic particles per milliliter of blood, a result which apparently put me at the low end of the range of possible results. I emailed Cohen to tell her I was pleased with my results. 'Glad you were pleasantly surprised, but that's still around a million particles in your circulatory system!' she responded.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Americans' becoming more aware of GLP-1 drugs like Ozempic, Wegovy: Survey
Americans' becoming more aware of GLP-1 drugs like Ozempic, Wegovy: Survey

The Hill

time3 hours ago

  • The Hill

Americans' becoming more aware of GLP-1 drugs like Ozempic, Wegovy: Survey

The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped significantly in the last few years, a new survey shows. The YouGov poll, released Friday, shows that at least 80 percent of respondents have heard at least 'a little bit' about semaglutide, a medication used to treat Type 2 diabetes that also helps a user to shed weight. In March 2023, only 60 percent of Americans were aware of the drug. A year later, in March 2024, that number had jumped to 70 percent, the pollster noted. The latest survey also shows that the share of those who have heard 'a lot' about the medication has nearly doubled since 2023, increasing to 41 percent from 23 percent. Just 36 percent of respondents say they know someone who has taken semaglutide. Around 14 percent listed a family member took the medicine, 16 percent named a friend, 11 percent identified an acquaintance and 7 percent said they had taken it themselves, according to the poll. Several also noted they knew a user in more than one category. Women are more likely than men, 43 percent to 29 percent, to know someone — including themselves — who has taken a GLP-1 agonist drug, per the survey. The weight loss medications — including Wegovy, Ozempic, Zepbound and others — have been available since 2005 but have only in the past few years been used to treat obesity. The drugs work by mimicking a hormone in the body — glucagon-like peptide-1 — that stimulates insulin secretion and reduces appetite. Possible side effects of taking the medication include nausea, diarrhea, vomiting, and constipation. While semaglutide is currently only prescribed for weight loss or treating diabetes, early research is pointing to possible benefits for a host of other issues, including treatment for addiction, neurodegenerative diseases and conditions that affect the heart, kidney or liver. The latest survey found that roughly a quarter of respondents said they would be 'very' or 'somewhat' interested in taking the medication as a weight loss treatment. About a third of Americans have either taken the drug or said they would be interested in trying it. On the other side, about 17 percent said they were 'not very' interested in the medication and 45 percent signaled they were not at all interested. A separate poll from last September found that around a quarter of adults in the U.S. would consider using weight loss medications without consulting their doctor. The YouGov analysis is based on an online survey conducted from May 22-25 among 1,109 adults in the U.S. The margin of error for the full sample is 4 percentage points.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store